Clinical activity, safety and predictive biomarkers results from a phase Ia atezolizumab (atezo) trial in extensive-stage small cell lung cancer (ES-SCLC)
Conference Paper
Full Text
Duke Authors
Cited Authors
- Sequist, LV; Chiang, A; Gilbert, J; Gordon, M; Conkling, PR; Thompson, D; Marcoux, JP; Antonia, SJ; Liu, B; Shames, DS; Lopez-Chavez, A; O'Hear, C; Fasso, M; Gettinger, S
Published Date
- October 1, 2016
Published In
Volume / Issue
- 27 /
Published By
Pages
- 1
Electronic International Standard Serial Number (EISSN)
- 1569-8041
International Standard Serial Number (ISSN)
- 0923-7534
Digital Object Identifier (DOI)
- 10.1093/annonc/mdw389.3